Myeloablative allogeneic stem cell transplantation for advanced stage multiple myeloma: very long-term follow up of a single center experience

被引:7
|
作者
Kennedy, G. A. [1 ]
Butler, J.
Morton, J.
Hill, G.
Western, R.
Cummings, J.
Allison, R.
Durrant, S.
机构
[1] Royal Brisbane & Womens Hosp, Dept Haematol, Div Oncol, Brisbane, Qld 4029, Australia
[2] Queensland Inst Med Res, Brisbane, Qld 4006, Australia
来源
CLINICAL AND LABORATORY HAEMATOLOGY | 2006年 / 28卷 / 03期
关键词
allogeneic stem cell transplantation; multiple myeloma; myeloablative;
D O I
10.1111/j.1365-2257.2006.00773.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We aimed to review the long-term outcome of myeloablative allogeneic stem cell transplantation (SCT) performed for multiple myeloma (MM) at our institution. Records of all patients who received standard myeloablative allogeneic SCT for MM were retrospectively reviewed. Overall survival (OS), progression-free survival (PFS), and event-free survival (EFS) were calculated using the Kaplan-Meier method. In total 37 transplants had been performed. Median follow up post-SCT was 108 months (range: 33-148). The majority of patients suffered advanced stage disease and/or had received multiple prior therapies prior to SCT. Transplant-related mortality (TRM) at 100 days was 32%. Grades 2-4 acute graft-vs.-host disease (GVHD) occurred in 18 patients (49%), and extensive stage chronic GVHD in seven (28%) of 25 patients surviving greater than day 100. Median OS, PFS, and EFS were 28 months, 66 months and 13 months, respectively, with 5 year OS, PFS, and EFS 40%, 54% and 24%. Our results suggest that allogeneic SCT, even when performed in advanced stage, heavily pretreated MM, still results in long-term EFS in a significant minority of patients. Efforts should continue on alternative allogeneic SCT approaches to reduce the high early TRM rate associated with myeloablative conditioning.
引用
收藏
页码:189 / 197
页数:9
相关论文
共 50 条
  • [1] Long-term results of myeloablative allogeneic stem cell transplantation in multiple myeloma
    Perrone, G.
    Bonifazi, F.
    Giovannini, M.
    Tosi, P.
    Arpinati, M.
    Stanzani, M.
    Ceccolini, M.
    Pallotti, M. C.
    Zamagni, E.
    Tacchetti, P.
    Brioli, A.
    Bandini, G.
    Baccarani, M.
    Cavo, M.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 99 - 99
  • [2] Long-term outcome of myeloablative allogeneic stem cell transplantation for multiple myeloma
    Kuruvilla, John
    Shepherd, Yohn D.
    Sutherland, Heather J.
    Nevill, Thomas J.
    Nitta, Janet
    Le, Aulan
    Forrest, Donna L.
    Hogge, Donna E.
    Lavoie, Julye C.
    Nantel, Stephen H.
    Toze, Cynthia L.
    Smith, Clayton A.
    Barnett, Micheal J.
    Song, Kevin W.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (08) : 925 - 931
  • [3] ALLOGENEIC STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA - A LONG-TERM FOLLOW-UP
    Weipert, A.
    Reibke, R.
    Braess, J.
    Tischer, J.
    Kolb, H.
    [J]. HAEMATOLOGICA, 2012, 97 : 340 - 341
  • [4] Long-term survival after allogeneic stem cell transplantation for advanced stage multiple myeloma
    Vekemans, Marie-Christiane
    Michaux, Lucienne
    Van den Neste, Eric
    Ferrant, Augustin
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2014, 166 (04) : 616 - 618
  • [5] Long-term outcome of autologous and myeloablative allogeneic stem cell transplantation for Multiple Myeloma.
    Kuruvilla, J
    Nevill, TJ
    Nitta, J
    Le, A
    Forrest, DL
    Lavoie, JC
    Nantel, SH
    Song, KW
    Sutherland, HJ
    Toze, CL
    Hogge, DE
    Shepherd, JD
    [J]. BLOOD, 2003, 102 (11) : 475A - 475A
  • [6] LONG-TERM FOLLOW-UP OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR MULTIPLE MYELOMA PATIENTS
    Lopez-Godino, O.
    Cabrero, M.
    Bastida, J. M.
    Lopez-Parra, M.
    Labrador, J.
    Perez-Lopez, E.
    Caballero, T.
    Sanchez-Guijo, F.
    Vazquez, L.
    Garcia-Sanz, R.
    Ocio, E. M.
    Gutierrez, N.
    Perez-Simon, J. A.
    Mateos, M. V.
    del Caizo, C.
    Caballero, D.
    Lopez-Corral, L.
    [J]. BONE MARROW TRANSPLANTATION, 2014, 49 : S356 - S356
  • [7] Allogeneic stem cell transplantation in patients with multiple myeloma: long term follow-up in a single centre
    Benakli, M.
    Nacer, R. Ahmed
    Talbi, A.
    Rahmoune, N.
    Mehdid, F.
    Baazizi, M.
    Belhadj, R.
    Ouali, D. Ait
    Hamladji, R. M.
    [J]. BONE MARROW TRANSPLANTATION, 2012, 47 : S327 - S327
  • [8] Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma for Long-Term Follow-up: Single Center Results
    Sui, Weiwei
    Zou, Dehui
    An, Gang
    Deng, Shuhui
    Xu, Yan
    Yi, Shuhua
    Li, Zengjun
    Zhao, Yaozhong
    Qiu, Lugui
    [J]. BLOOD, 2016, 128 (22)
  • [9] Allogeneic Stem Cell Transplantation for Multiple Myeloma: a Single Center Experience
    Figueiredo, Amarilis
    Atkins, Harold
    Kekre, Natasha
    Kew, Andrea
    McCurdy, Arleigh
    [J]. BLOOD, 2016, 128 (22)
  • [10] Allogeneic Stem Cell Transplantation with Omidubicel: Long-Term Follow-up from a Single Center
    Lin, Chenyu
    Morrison, Laura
    Alyea, Edwin P., III
    Choi, Taewoong
    Gasparetto, Cristina
    Long, Gwynn D.
    Lopez, Richard D.
    Rizzieri, David A.
    Sarantopoulos, Stefanie
    Sung, Anthony D.
    Chao, Nelson J.
    Galamidi-Cohen, Einat
    Schwarzbach, Aurelie
    Horwitz, Mitchell E.
    [J]. BLOOD, 2021, 138 : 1827 - +